BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
- Written by PR Newswire
![]() |
- BioDlink has been named "Emerging CDMO of the Year" for its innovation in complex biologics and ADC development.
- The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed.
SUZHOU, China, March 13, 2026 /PRNewswire/ -- BioDlink, an innovation-driven Contract...














